These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8542052)

  • 1. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures.
    Stempel DA; Hedblom EC; Durcanin-Robbins JF; Sturm LL
    Arch Fam Med; 1996 Jan; 5(1):36-40. PubMed ID: 8542052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and cost of sildenafil in a large managed care organization with a quantity limit on sildenafil.
    Cooke CE; Wong W; Lee H
    J Manag Care Pharm; 2005 Oct; 11(8):674-80. PubMed ID: 16194131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists.
    Stempel DA; Durcannin-Robbins JF; Hedblom EC; Woolf R; Sturm LL; Stempl AB
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):153-8. PubMed ID: 8595534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
    O'Connor RD; Parasuraman B; Roberts C; Leibman C
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of short-term inpatient rehabilitation for children with severe asthma.
    Weinstein AG; McKee L; Stapleford J; Faust D
    J Allergy Clin Immunol; 1996 Aug; 98(2):264-73. PubMed ID: 8757202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS; Davis EA; Stanford RH
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
    Margolis J; Barron JJ; Grochulski WD
    J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative costs of urgent care services in university-based clinical sites.
    Warren BH; Isikoff SJ
    Arch Fam Med; 1993 May; 2(5):523-8. PubMed ID: 8118568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actuarial analysis of private payer administrative claims data for women with endometriosis.
    Mirkin D; Murphy-Barron C; Iwasaki K
    J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
    Park CS; Kang HY; Kwon I; Kang DR; Jung HY
    J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of medical care for injuries to children.
    Malek M; Chang BH; Gallagher SS; Guyer B
    Ann Emerg Med; 1991 Sep; 20(9):997-1005. PubMed ID: 1908648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An employer perspective on annual employee and dependent costs for pediatric asthma.
    Kleinman NL; Brook RA; Ramachandran S
    Ann Allergy Asthma Immunol; 2009 Aug; 103(2):114-20. PubMed ID: 19739423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board.
    Ungar WJ; Coyte PC; Chapman KR; MacKeigan L
    Can Respir J; 1998; 5(6):463-71. PubMed ID: 10070174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.
    Lozano P; Fishman P; VonKorff M; Hecht J
    Pediatrics; 1997 Jun; 99(6):757-64. PubMed ID: 9164766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and predictors of emergency department charges: the case of a tertiary hospital in Lebanon.
    Saleh S; Mourad Y; Dimassi H; Hitti E
    BMC Health Serv Res; 2016 Mar; 16():97. PubMed ID: 26993108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.